Date
Time
Join us for a groundbreaking exploration of small interfering RNA (siRNA) technology and its transformative potential in hemophilia treatment. In this cutting-edge session, leading researchers and clinical experts will unveil how siRNA therapies are revolutionizing our approach to clotting disorders by targeting the underlying genetic mechanisms.
This isn't just about another treatment option—it represents a fundamental shift in how we manage hemophilia. Through years of innovative research and development, siRNA-based approaches offer new hope for patients by silencing specific genes that contribute to clotting challenges, potentially reducing treatment burden and improving quality of life.
What You'll Learn:
- The science behind siRNA technology and how it differs from traditional hemophilia treatments
- Latest clinical trial results showing the effectiveness of gene silencing approaches
- How these therapies might address inhibitor development and other treatment challenges
- Patient perspectives on living with novel siRNA therapies
- The future landscape of genetic interventions for bleeding disorders
- Opportunities to participate in research and clinical trials exploring these innovative approaches
Whether you're a patient, caregiver, healthcare provider, researcher, or simply interested in breakthrough medical technologies, this session will provide valuable insights into one of the most promising frontiers in hemophilia care.
About Wednesday Webinars with NBDF:
The National Bleeding Disorders Foundation (NBDF) Wednesday Webinars includes a series of free educational one-hour webinars (up to 40-minute live Zoom presentation, followed by 20-minute moderated Q&A) aims to bring knowledge about the latest research, breakthrough developments, and more to the bleeding and blood disorders community. Each webinar is held at 2 PM EDT.